Patents Assigned to Napo Pharmaceuaticals, Inc.
  • Patent number: 8067041
    Abstract: The present invention provides methods for treating constipation-predominant irritable bowel syndrome comprising administering to a patient in need thereof, a polymeric proanthocyanidin composition from a Croton species or Calophyllum species in an amount sufficient to treat constipation-predominant irritable bowel syndrome (c-IBS). Treatment of c-IBS includes the treatment of the constipation component of c-IBS as well as the pain and abdominal discomfort associated with c-IBS. In one embodiment, the polymeric proanthocyanidin compound is crofelemer. The present invention in an alternative embodiment also provides methods for treating alternating constipation-predominant/diarrhea-predominant irritable bowel syndrome.
    Type: Grant
    Filed: June 2, 2009
    Date of Patent: November 29, 2011
    Assignee: Napo Pharmaceuaticals, Inc.
    Inventors: Barry D. Quart, David P. Rosenbaum